Top 28 Spruce Street Capital LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| RLMD | RELMADA THERAPEUTICS INC | 10.34% | 6.26M | $43.0M | +53.25%(+2.18M) | $4.28(+46.73%) | 2026-03-31 | |
| KNSA | KINIKSA PHARMACEUTICALS I | 8.81% | 761.1K | $36.6M | +74.96%(+326.08K) | $42.04(+53.51%) | 2026-03-31 | |
| LBRX | LB PHARMACEUTICALS INC | 8.09% | 1.38M | $33.6M | +36.85%(+370.57K) | $20.22(+65.34%) | 2026-03-31 | |
| DNTH | DIANTHUS THERAPEUTICS IN | 7.53% | 373.3K | $31.3M | +25.50%(+75.84K) | $44.81(+110.54%) | 2026-03-31 | |
| RLAY | RELAY THERAPEUTICS INC | 7.14% | 2.98M | $29.7M | +0.00%(+0) | $6.84(+172.66%) | 2026-03-31 | |
| ANRO | ALTO NEUROSCIENCE INC | 7% | 1.33M | $29.1M | +494.68%(+1.10M) | $18.59(+33.31%) | 2026-03-31 | |
| CNTA | CENTESSA PHARMACEUTICALS | 4.68% | 489.8K | $19.5M | +528.04%(+411.85K) | $31.13(+30.09%) | 2026-03-31 | |
| SVRA | SAVARA INC | 4.44% | 3.38M | $18.5M | +40.32%(+972.08K) | $5.07(+22.65%) | 2026-03-31 | |
| KALV | KALVISTA PHARMACEUTICALS | 4.34% | 897.7K | $18.1M | +131.38%(+509.71K) | $16.42(+62.77%) | 2026-03-31 | |
| PCVX | VAXCYTE INC | 3.43% | 245.7K | $14.3M | -38.63%(-154.65K) | $41.08(+42.14%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +251.96% | +4259.81% |
| Top 20 Holdings Unweighted | +225.18% | +3338.52% |
Sign up free to track Spruce Street Capital LP, compare funds side by side, and get alerts the moment positions change.